Qinjie Wu
- Molecular Medicine top 0.5%
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery 23
- Rehabilitation top 1%
- Pharmaceutical Science top 1%
- Biomedical Engineering top 2%
- Nanoplatforms for cancer theranostics 27
-
- RNA Interference and Gene Delivery 27
- CRISPR and Genetic Engineering 11
-
- Immunotherapy and Immune Responses 14
- Immune cells in cancer 10
-
- Virus-based gene therapy research 11
-
- Hernia repair and management 9
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Qinjie Wu
89 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Molecular Medicine 805
- Biomaterials 1.5k
- Rehabilitation 400
- Pharmaceutical Science 348
- Biomedical Engineering 1.2k
Countries citing papers authored by Qinjie Wu
This map shows the geographic impact of Qinjie Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qinjie Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qinjie Wu more than expected).
Fields of papers citing papers by Qinjie Wu
This network shows the impact of papers produced by Qinjie Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qinjie Wu. The network helps show where Qinjie Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qinjie Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 5 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 7 | |
| 7 | 2024 | 19 | |
| 8 | 2023 | 13 | |
| 9 | 2023 | 15 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 5 | |
| 12 | 2021 | 13 | |
| 13 | 2019 | 74 | |
| 14 | 2016 | 51 | |
| 15 | 2014 | 7 | |
| 16 | 2014 | 8 | |
| 17 | A biodegradable hydrogel system containing curcumin encapsulated in micelles for cutaneous wound healingbreakdown → | 2013 | 457 |
| 18 | 2013 | 32 | |
| 19 | 2012 | 111 | |
| 20 | 2011 | 38 |
About Qinjie Wu
Qinjie Wu is a scholar working on Biomaterials, Molecular Medicine and Immunology, having authored 92 papers that have together received 4.2k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (27 papers), Nanoplatforms for cancer theranostics (27 papers), Nanoparticle-Based Drug Delivery (23 papers), Immunotherapy and Immune Responses (14 papers), Virus-based gene therapy research (11 papers), CRISPR and Genetic Engineering (11 papers), Immune cells in cancer (10 papers) and Hernia repair and management (9 papers). The work is most often cited by research in Molecular Medicine (805 citations), Biomaterials (1.5k citations) and Rehabilitation (400 citations). Qinjie Wu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Changyang Gong, Yuquan Wei, Zhiyong Qian, Lu Sun, Linjiang Song, Feng Luo, Doudou Zhang, Tao He, Xi Yang and Xia Zhao.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.